Anand Bhaskar 4
4 · Summit Therapeutics Inc. · Filed Apr 4, 2024
Insider Transaction Report
Form 4
Anand Bhaskar
Chief Accounting Officer
Transactions
- Award
Stock Option (right to buy)
2024-04-02+600,000→ 600,000 totalExercise: $3.85Exp: 2034-04-02→ Common Stock (600,000 underlying)
Footnotes (2)
- [F1]The option was granted on April 2, 2024. The shares underlying the option shall vest in four equal annual installments, with the first such installment occurring on April 2, 2025. Note this does not include an additional 600,000 options which were granted on April 2, 2024 and are subject to the satisfaction of performance conditions based on market capitalization and revenue targets.
- [F2]Not applicable.